Health Care

Shares of Synergy Pharmaceuticals rose about 10 percent Thursday after the company said its constipation drug plecanatide met its goals in a second late-stage study.

An Ohio company is recalling about 90,000 SUV tires because the tread can separate, causing a loss of air and increasing the risk of a crash.

Whirlpool is recalling more than 40,000 of its Jenn-Air brand ovens after customers reported burns due to faulty oven racks.

Mini is recalling about 35,000 cars in the U.S. and Canada because they don't meet side-impact crash-test requirements.

U.S. auto safety regulators have rejected a request to investigate power system failures in almost 5 million Fiat Chrysler vehicles.

Federal health regulators say they have approved an inflatable medical balloon that helps patients lose weight by filling up space in the stomach.

Fiat Chrysler could be required to lay out hundreds of millions of dollars to get potentially defective Ram pickups and older Jeeps off the road under a deal with safety regulators to settle claims that the automaker mishandled nearly two dozen recalls.

Fiat Chrysler said Saturday that it is recalling more than half a million more trucks in the U.S. to fix faulty impact sensors, a day after it announced an even bigger U.S. recall to update vehicles' software in order to safeguard it from hacking.

The U.S. government will hit Fiat Chrysler with a record $105 million fine next week for violating laws in a series of vehicle safety recalls, a person briefed on the matter said.

More than 140,000 night lights are being recalled because they can overheat and spark a fire.

A new drug for advanced basal cell carcinoma, an increasingly common cancer in the skin's top layer, has won Food and Drug Administration approval.

The Food and Drug Administration says it has approved a breakthrough drug that lowers bad cholesterol more than older medicines that have been prescribed for decades.

Valeant Pharmaceuticals turned in quarterly results that topped analysts' estimates on Thursday, as adjusted earnings and sales climbed.

Shares of Sunesis Pharmaceuticals plunged in aftermarket trading Thursday after the company said it will focus on trying to get its blood cancer drug Qinprezo on the market in Europe because regulators in the U.S. won't approve it based on available data.

The Federal Trade Commission is investigating General Motors because of dealers who advertised certified used cars for sale even though they still needed repairs under existing recalls.

Fiat Chrysler is recalling nearly 350,000 crossover SUVs to fix engine covers that could come loose and catch fire.

Swiss-based pharmaceutical company Novartis says second-quarter net income dropped 32 percent over the same quarter last year, brought down primarily by poor performance from associated companies and negative effects of a strong U.S. dollar.

Amgen Inc. says European regulators have approved its first-of-a-kind cholesterol drug that lowers levels of the artery-clogging substance more than older drugs that have been prescribed for decades.

One of the companies that had been studying a potential treatment for the Ebola virus said Monday it will suspend its research on Ebola drugs and change its name.

One university's effort to poach a star faculty member at another Southern California university has devolved into a legal battle that some fear may impede Alzheimer's disease research.